Skip to main content
. Author manuscript; available in PMC: 2014 Jan 30.
Published in final edited form as: Vaccine. 2011 Nov 7;30(1):29–34. doi: 10.1016/j.vaccine.2011.10.068

Figure 1. Geometric mean titers (GMTs) at baseline, 1 month or 12 months after vaccination with MenACWY-CRM or MPSV-4, as measured by SBA using human (hSBA) or rabbit (rSBA) serum as the complement source.

Figure 1

Figure 1

summarizes the geometric mean titers for meningococcal serogroups A, C, W-135 and Y, as measured by hSBA (Figure 1a) and rSBA (Figure 1b). For each serogroup, results are presented in pairs, representing subjects who received MenACWY-CRM or MPSV-4, and by time period: baseline, 1 month after vaccination, and 12 months after vaccination. GMTs are expressed on a log scale, with the precise value displayed over the top of each histogram.